Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Subst Abuse Treat. 2019 Aug 7;106:19–28. doi: 10.1016/j.jsat.2019.08.002

Table 3.

Acceptability of buprenorphine treatment as reported by participants at follow-up 1, by assigned condition in the parent study

  BUP
N=460
MET
N=329
Total
N=789
Currently taking buprenorphine N (%)  N (%)  N (%) 
Among participants with knowledge of buprenorphine n=457 n=230 n=687
Yes 80 (17.5) 39 (17.0) 119 (17.3)
     
Willingness to take buprenorphine if available*      
Among patients not taking buprenorphine n=377 n=191 n=568
No 183 (48.5) 111 (58.1) 294 (51.8)
     
Reasons not willing to take buprenorphine      
Among patients not taking buprenorphine and unwilling to take buprenorphine n=183 n=111 n=294
Not using opioids now 99 (54.1) 52 (46.9) 151 (51.4)
Prefer methadone 81 (44.3) 55 (49.6) 136 (46.3)
Do not like buprenorphine^** 70 (38.3) 26 (23.4) 96 (32.7)
Cannot find free buprenorphine* 39 (21.3) 12 (10.8) 51 (17.4)
Don't know much about buprenorphine 15 (8.2) 16 (14.4) 31 (10.5)
Heard bad things about buprenorphine^ 15 (8.2) 7 (6.3) 22 (7.5)
Other reasons 26 (14.2) 23 (20.7) 49 (16.7)
Reasons for not liking buprenorphine      
Among patients not taking buprenorphine who do not like buprenorphine n=70 n=26 n=96
Had negative physical reactions^* 51 (72.9) 13 (50.0) 64 (66.7)
Did not like the side effects^* 33 (47.1) 6 (23.1) 39 (40.6)
Medication was not strong enough^ 21 (30.0) 13 (50.0) 34 (35.4)
Can’t feel opioids when taking buprenorphine^* 29 (41.4) 4 (15.4) 33 (34.4)
Had to come to clinic everyday*** 27 (38.6) 0 (0.0) 27 (28.1)
Other reasons 10 (14.3) 7 (26.9) 17 (17.7)
Acceptability of buprenorphine treatment composite score (range: −6 to 0), Mean (SD) −0.72 (1.19) −0.46 (0.81) −0.62 (1.05)
*

p<0.05,

**

p<0.01,

***

p<0.001;

X2 tests for categorical variables and t-tests for continuous variables.

^

item was used to create the acceptability composite score.